Recombinant Human NGAL

NGAL is a new early marker for acute kidney injury. Levels rise rapidly after renal injury and have been used in a variety of clinical situations including intensive care, emergency medicine, renal transplantation and procedures involving the use of i.v.contrast media and other nephrotoxic agents. Studies have indicated that this marker has the greatest potential for the prediction and monitoring of acute renal injury following cardiac surgery. This potential has now been expanded upon, with development and commercialisation of highly specific ELISA testing kits.
More Information
Abbreviation NGAL
Disease Area Inflammation Markers
Keywords Recombinant , Lipocalin-2, NGAL, Lipo, neutrophil, gelatinase, lipocalin
Molecular Weight 23674 Da
NCBI Entrez Gene ID 3934
Presentation Matrix lyophilised from 0.02M NH4HCO3
Product Category Recombinant Antigens
Purity/Grade >96%
Recommended Use


Shipping Recommendation 4°C is acceptable
Source Expressed in yeast
Storage -15°C
UniProt Number P80188
Copyright © 2019 BBI Solutions. All rights reserved. Designed trademarks and brands are the property of their respective owners. BBIUS